# Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)

> **NCT02412267** · PHASE2 · COMPLETED · sponsor: **National Cancer Centre, Singapore** · enrollment: 17 (actual)

## Conditions studied

- Diffuse Large B-cell Lymphoma

## Interventions

- **DRUG:** O-ICE (ofatumumab, Ifosfamide, Carboplatin, Etoposide)

## Key facts

- **NCT ID:** NCT02412267
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2015-12
- **Final completion:** 2016-03
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-03-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412267, "Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02412267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*